Literature DB >> 9292395

Wine as a biological fluid: history, production, and role in disease prevention.

G J Soleas1, E P Diamandis, D M Goldberg.   

Abstract

Wine has been part of human culture for 6,000 years, serving dietary and socio-religious functions. Its production takes place on every continent, and its chemical composition is profoundly influenced by enological techniques, the grape cultivar from which it originates, and climatic factors. In addition to ethanol, which in moderate consumption can reduce mortality from coronary heart disease by increasing high-density lipoprotein cholesterol and inhibiting platelet aggregation, wine (especially red wine) contains a range of polyphenols that have desirable biological properties. These include the phenolic acids (p-coumaric, cinnamic, caffeic, gentisic, ferulic, and vanillic acids), trihydroxy stilbenes (resveratrol and polydatin), and flavonoids (catechin, epicatechin, and quercetin). They are synthesized by a common pathway from phenylalanine involving polyketide condensation reactions. Metabolic regulation is provided by competition between resveratrol synthase and chalcone synthase for a common precursor pool of acyl-CoA derivatives. Polymeric aggregation gives rise, in turn to the viniferins (potent antifungal agents) and procyanidins (strong antioxidants that also inhibit platelet aggregation). The antioxidant effects of red wine and of its major polyphenols have been demonstrated in many experimental systems spanning the range from in vitro studies (human low-density lipoprotein, liposomes, macrophages, cultured cells) to investigations in healthy human subjects. Several of these compounds (notably catechin, quercetin, and resveratrol) promote nitric oxide production by vascular endothelium; inhibit the synthesis of thromboxane in platelets and leukotriene in neutrophils, modulate the synthesis and secretion of lipoproteins in whole animals and human cell lines, and arrest tumour growth as well as inhibit carcinogenesis in different experimental models. Target mechanisms to account for these effects include inhibition of phospholipase A2 and cyclo-oxygenase, inhibition of phosphodiesterase with increase in cyclic nucleotide concentrations, and inhibition of several protein kinases involved in cell signalling. Although their bioavailability remains to be fully established, red wine provides a more favourable milieu than fruits and vegetables, their other dietary source in humans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9292395      PMCID: PMC6760744     

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  151 in total

1.  A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein.

Authors:  S Parthasarathy; E Wieland; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

2.  Immunochemical evidence for the involvement of prostaglandin H synthase in hydroperoxide-dependent oxidations by ram seminal vesicle microsomes.

Authors:  W R Pagels; R J Sachs; L J Marnett; D L Dewitt; J S Day; W L Smith
Journal:  J Biol Chem       Date:  1983-05-25       Impact factor: 5.157

3.  Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation.

Authors:  I B Afanas'ev; A I Dorozhko; A V Brodskii; V A Kostyuk; A I Potapovitch
Journal:  Biochem Pharmacol       Date:  1989-06-01       Impact factor: 5.858

4.  Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases.

Authors:  K Ono; H Nakane; M Fukushima; J C Chermann; F Barré-Sinoussi
Journal:  Eur J Biochem       Date:  1990-07-05

5.  The effects of the bioflavonoid quercetin on squamous cell carcinoma of head and neck origin.

Authors:  M H Castillo; E Perkins; J H Campbell; R Doerr; J M Hassett; C Kandaswami; E Middleton
Journal:  Am J Surg       Date:  1989-10       Impact factor: 2.565

6.  Caffeic and ferulic acid as blockers of nitrosamine formation.

Authors:  W Kuenzig; J Chau; E Norkus; H Holowaschenko; H Newmark; W Mergens; A H Conney
Journal:  Carcinogenesis       Date:  1984-03       Impact factor: 4.944

Review 7.  Phospholipase A2--a mediator between proximal and distal effectors of inflammation.

Authors:  W Pruzanski; P Vadas
Journal:  Immunol Today       Date:  1991-05

8.  Effects of ethanol on pathways of platelet aggregation in vitro.

Authors:  M L Rand; M A Packham; R L Kinlough-Rathbone; J Fraser Mustard
Journal:  Thromb Haemost       Date:  1988-06-16       Impact factor: 5.249

9.  Ability of m-chloroperoxybenzoic acid to induce the ornithine decarboxylase marker of skin tumor promotion and inhibition of this response by gallotannins, oligomeric proanthocyanidins, and their monomeric units in mouse epidermis in vivo.

Authors:  G Chen; E M Perchellet; X M Gao; S W Newell; R W Hemingway; V Bottari; J P Perchellet
Journal:  Anticancer Res       Date:  1995 Jul-Aug       Impact factor: 2.480

10.  Quercetin inhibits tyrosine phosphorylation by the cyclic nucleotide-independent, transforming protein kinase, pp60src.

Authors:  H Glossmann; P Presek; E Eigenbrodt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-08       Impact factor: 3.000

View more
  74 in total

1.  Response of plasma lipids to dietary cholesterol and wine polyphenols in rats fed polyunsaturated fat diets.

Authors:  L Frémont; M T Gozzelino; A Linard
Journal:  Lipids       Date:  2000-09       Impact factor: 1.880

2.  Effects of resveratrol in inflammatory arthritis.

Authors:  N Elmali; O Baysal; A Harma; I Esenkaya; B Mizrak
Journal:  Inflammation       Date:  2007-04       Impact factor: 4.092

Review 3.  Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.

Authors:  Mahmoud Alhosin; Tanveer Sharif; Marc Mousli; Nelly Etienne-Selloum; Guy Fuhrmann; Valérie B Schini-Kerth; Christian Bronner
Journal:  J Exp Clin Cancer Res       Date:  2011-04-15

Review 4.  Prevention of cardiovascular risk by moderate alcohol consumption: epidemiologic evidence and plausible mechanisms.

Authors:  Augusto Di Castelnuovo; Simona Costanzo; Maria Benedetta Donati; Licia Iacoviello; Giovanni de Gaetano
Journal:  Intern Emerg Med       Date:  2010-02-03       Impact factor: 3.397

5.  Modulation of folate uptake in cultured human colon adenocarcinoma Caco-2 cells by dietary compounds.

Authors:  Clara Lemos; Godefridus J Peters; Gerrit Jansen; Fátima Martel; Conceição Calhau
Journal:  Eur J Nutr       Date:  2007-08-21       Impact factor: 5.614

6.  (±)-Diinsininone: made nature's way.

Authors:  Carolyn Selenski; Thomas R R Pettus
Journal:  Tetrahedron       Date:  2006-05-29       Impact factor: 2.457

7.  Resveratrol (trans-3,5,4'-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor.

Authors:  Narendra P Singh; Venkatesh L Hegde; Lorne J Hofseth; Mitzi Nagarkatti; Prakash Nagarkatti
Journal:  Mol Pharmacol       Date:  2007-09-14       Impact factor: 4.436

Review 8.  The biological responses to resveratrol and other polyphenols from alcoholic beverages.

Authors:  Lindsay Brown; Paul A Kroon; Dipak K Das; Samarjit Das; Arpad Tosaki; Vincent Chan; Manfred V Singer; Peter Feick
Journal:  Alcohol Clin Exp Res       Date:  2009-06-10       Impact factor: 3.455

9.  Retinal protective effects of resveratrol via modulation of nitric oxide synthase on oxygen-induced retinopathy.

Authors:  Woo Taek Kim; Eok Soo Suh
Journal:  Korean J Ophthalmol       Date:  2010-04-06

10.  Red wine polyphenols for cancer prevention.

Authors:  Shan He; Cuirong Sun; Yuanjiang Pan
Journal:  Int J Mol Sci       Date:  2008-05-20       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.